Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul;11(7):2689-2694.
doi: 10.21037/jtd.2019.06.53.

Contrast induced acute kidney injury and the role of beta-blockers in its prevention

Umberto Barbero  1 , Mario Iannaccone  1 , Michele De Benedictis  1 , Baldassarre Doronzo  1
Affiliations
Editorial

Contrast induced acute kidney injury and the role of beta-blockers in its prevention

Umberto Barbero et al. J Thorac Dis. 2019 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Some of the most used risk scores [Mehran score (4), Bartholomew score (15) and Maioli score (16)] for CI-AKI with the derived classification and associated risk. CIN, contrast-induced nephropathy; CI-AKI, contrast-induced acute kidney injury.
See this image and copyright information in PMC

Comment on

References

    1. Liu J, Sun G, He Y, et al. Early β-blockers administration might be associated with a reduced risk of contrast-induced acute kidney injury in patients with acute myocardial infarction. J Thorac Dis 2019;11:1589-96. 10.21037/jtd.2019.04.65 - DOI - PMC - PubMed
    1. Leoncini M, Toso A, Maioli M, et al. Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome. J Am Coll Cardiol 2014;63:71-9. 10.1016/j.jacc.2013.04.105 - DOI - PubMed
    1. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-5. 10.1016/j.jacc.2004.07.043 - DOI - PubMed
    1. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;44:1393-9. - PubMed
    1. Lindsay J, Apple S, Pinnow EE, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003;59:338-43. 10.1002/ccd.10534 - DOI - PubMed